Navigation Links
Depomed Reports Third Quarter 2013 Financial Results
Date:11/5/2013

NEWARK, Calif., Nov. 5, 2013 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today reported financial results for the quarter ended September 30, 2013.

Third Quarter 2013 Financial and Operational Summary

  • Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795. Excluding this milestone and a $10 million upfront payment from Janssen in the third quarter of 2012, total revenues of $32.5 million grew 39% compared to $23.3 million for the third quarter of 2012.
  • Product revenues of $16.3 million grew 68% compared to $9.7 million for the third quarter of 2012.
  • Gralise® (gabapentin) net sales of $9.8 million grew 104% compared to $4.8 million for the third quarter of 2012.
  • Zipsor® (diclofenac potassium) net sales of $6.0 million grew 22% compared to $4.9 million for the third quarter of 2012.
  • Glumetza® (metformin hydrochloride extended-release) royalties from Santarus, Inc. of $14.6 million, compared to $11.6 million for the third quarter of 2012.
  • Net income of $6.5 million or $0.11 per share, compared to a net loss of ($1.5) million or ($0.03) per share for the third quarter of 2012.
  • Cash and marketable securities of $85.4 million as of September 30, 2013; does not include proceeds of the $240.5 million from PDL BioPharma announced in October 2013.
  • Depomed acquired and launched Lazanda® (fentanyl) Nasal Spray for the treatment of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. 
  • In October, Depomed sold its royalty and milestone interest in its type 2 diabetes portfolio to PDL BioPharma, generating $240.5 million.<
    '/>"/>

  • SOURCE Depomed, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
    2. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
    3. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
    4. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
    5. Depomed Reports Second Quarter 2013 Financial Results
    6. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
    7. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
    8. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
    9. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
    10. Depomed To Present At Jefferies 2013 Global Healthcare Conference
    11. Depomed Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
    (Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
    (Date:1/22/2015)... OAKS, Calif. , Jan. 22, 2015  Amgen (NASDAQ: ... and full year 2014 financial results on Tuesday, Jan. 27, 2015, ... be followed by a conference call with the investment community at ... Robert A. Bradway , chairman and chief executive officer, and ...
    Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
    ... , , ... ... ... ...
    ... , , CHAPEL HILL, N.C. ... to adjust its sales force structures in the face of marketplace ... to new research from Best Practices, LLC. , One of the ... territory size to better focus reps on customer needs, according to ...
    Cached Medicine Technology:Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight 2Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight 3Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight 4Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight 5Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight 6As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC 2As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC 3
    (Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
    (Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
    (Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
    (Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
    (Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
    ... in Southborough MA and agrees to ... open Second Pharmacy in Lynn MA, BANGOR, ... today announced that it has acquired the remaining 20%,interest in its ... As consideration for the minority interest,the former minority shareholders received a ...
    ... name as part of new parent company for ... Batesville Casket Company, Stand alone ... doing business under well-known ... HB ) announced today that it has begun mailing a,notice regarding a ...
    ... details differences between genders, ethnic groups , , FRIDAY, Feb. ... on your body, the greater your odds of developing ... only of fairly common cancers such as colon and ... Moreover, the degree of risk differs between men and ...
    ... (COPD) were less likely to receive a lung ... removed from the transplant list than whites, according ... These disparities are consistent with those observed among ... patients with other advanced lung diseases such as ...
    ... that a single prostate specific antigen (PSA) test at age ... up to 25 years later, (regardless of clinical significance) have ... predict advanced prostate cancer. , The findings, published in ... identify which men would benefit from intensive screening. , More ...
    ... Agency for,International Development (USAID) announced a $70 million, ... developing countries.,Fistula Care aims to increase access to ... strengthen their capacity to provide surgical,fistula repair. The ... to increase understanding about obstetric fistula and steps ...
    Cached Medicine News:Health News:Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements 2Health News:Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 4Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 5Health News:Obesity Raises Cancer Risk 2Health News:Obesity Raises Cancer Risk 3Health News:Blacks awaiting lung transplants more likely to die or be denied than whites 2Health News:Blacks awaiting lung transplants more likely to die or be denied than whites 3Health News:Early warning: PSA testing can predict advanced prostate cancer 2Health News:USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula 2
    ... Merit Medical is pleased to ... procedures. The pre-coated, high-performance, InQwire guide ... which is very lubricious and can ... is available in a wide range ...
    BiodivYsio stent with biocompatible coating (phosphorylcholine)...
    PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
    9mm Gently Curved Jaws, WIth Lock, in Titanium....
    Medicine Products: